PBX3
Basic information
Region (hg38): 9:125747345-125967377
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PBX3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 0 | 0 |
Variants in PBX3
This is a list of pathogenic ClinVar variants found in the PBX3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-125747475-C-G | not specified | Uncertain significance (Feb 12, 2024) | ||
9-125747544-C-T | not specified | Uncertain significance (Mar 28, 2024) | ||
9-125747619-A-G | not specified | Uncertain significance (Jun 05, 2023) | ||
9-125747625-G-C | not specified | Uncertain significance (Sep 29, 2023) | ||
9-125748570-A-G | not specified | Uncertain significance (Apr 19, 2023) | ||
9-125748585-C-G | not specified | Uncertain significance (Oct 26, 2022) | ||
9-125748585-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
9-125748605-G-C | not specified | Uncertain significance (Nov 15, 2024) | ||
9-125748621-CA-C | X-linked cone-rod dystrophy | Likely pathogenic (Jan 03, 2023) | ||
9-125915800-C-T | not specified | Uncertain significance (Nov 09, 2022) | ||
9-125915817-G-A | not specified | Uncertain significance (Jul 05, 2023) | ||
9-125915820-G-A | not specified | Uncertain significance (Nov 27, 2024) | ||
9-125915824-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
9-125929710-C-T | not specified | Uncertain significance (Oct 29, 2021) | ||
9-125935483-G-A | not specified | Uncertain significance (Aug 12, 2024) | ||
9-125935561-A-C | X-linked cone-rod dystrophy | Uncertain significance (Jan 03, 2023) | ||
9-125960725-G-T | not specified | Uncertain significance (Apr 09, 2024) | ||
9-125960784-C-CT | X-linked cone-rod dystrophy | Likely pathogenic (Jan 03, 2023) | ||
9-125960786-G-GTA | X-linked cone-rod dystrophy | Likely pathogenic (Jan 03, 2023) | ||
9-125962156-A-G | not specified | Uncertain significance (Oct 06, 2022) | ||
9-125962180-A-C | not specified | Uncertain significance (Jan 22, 2024) | ||
9-125962194-G-A | not specified | Uncertain significance (Oct 12, 2021) | ||
9-125963005-C-A | Likely benign (May 24, 2018) | |||
9-125963025-G-A | not specified | Uncertain significance (Jun 11, 2021) | ||
9-125963028-A-G | not specified | Uncertain significance (Apr 20, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PBX3 | protein_coding | protein_coding | ENST00000373489 | 9 | 220033 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.363 | 0.637 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.16 | 147 | 242 | 0.608 | 0.0000123 | 2846 |
Missense in Polyphen | 22 | 85.444 | 0.25748 | 1036 | ||
Synonymous | 0.578 | 85 | 92.1 | 0.923 | 0.00000516 | 818 |
Loss of Function | 3.37 | 5 | 22.1 | 0.226 | 0.00000119 | 249 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000108 | 0.0000967 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000656 | 0.0000653 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional activator that binds the sequence 5'- ATCAATCAA-3'.;
- Pathway
- Transcriptional misregulation in cancer - Homo sapiens (human);Mesodermal Commitment Pathway;miR-509-3p alteration of YAP1-ECM axis
(Consensus)
Recessive Scores
- pRec
- 0.0726
Intolerance Scores
- loftool
- 0.193
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.64
Haploinsufficiency Scores
- pHI
- 0.253
- hipred
- Y
- hipred_score
- 0.673
- ghis
- 0.507
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pbx3
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- regulation of respiratory gaseous exchange by neurological system process;anterior compartment pattern formation;posterior compartment specification;respiratory gaseous exchange;adult locomotory behavior;dorsal spinal cord development;positive regulation of transcription by RNA polymerase II;neuron development
- Cellular component
- nucleus;transcription factor complex
- Molecular function
- RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific